Skip to main content
S 350 117th Congress Senate Health Child health Congressional oversight Drug safety, medical device, and laboratory regulation Genetics Government studies and investigations Health information and medical records Health promotion and preventive care Health technology, devices, supplies Medical ethics Medical research Medical tests and diagnostic methods State and local government operations

Newborn Screening Saves Lives Reauthorization Act of 2021

Introduced: February 22, 2021 Introduced by: Hassan, Margaret Wood Democratic · New Hampshire See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 22, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 22, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Newborn Screening Saves Lives Reauthorization Act of 2021

This bill reauthorizes through FY2026 and revises several programs and activities relating to newborn screening for certain conditions and genetic, endocrine, and metabolic diseases.

Among its changes, the bill reauthorizes and makes mandatory

  • the Hunter Kelly Research Program at the National Institutes of Health, and
  • national surveillance activities conducted by the Centers for Disease Control and Prevention.

The bill also aligns statutory requirements for research on non-identified newborn blood spots with federal regulations governing research on human subjects. These blood spots are collected as part of newborn screening programs, and some states make them available for biomedical and public health research. Under current regulations, research on non-identified bio-specimens such as blood spots is not considered to be research on human subjects, to which additional protections apply.

What's happening now February 22, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 350: Newborn Screening Saves Lives Reauthorization Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-350/
MLA
"S. 350: Newborn Screening Saves Lives Reauthorization Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-350/.
Bluebook (legal)
S. 350, 117th Cong. (2026), https://openamerica.io/bill/117-S-350/.
Markdown link
[S. 350: Newborn Screening Saves Lives Reauthorization Act of 2021](https://openamerica.io/bill/117-S-350/)
Report a problem